[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"vestibular-disorder\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:vestibular-disorder":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,12,0,[8,47,77,100,123,146,171,208,227,256,278,300],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100569002","testing-effectiveness-of-a-stochastic-noise-stimulator-to-immediately-improve-balance-and-gait-100569002",false,"NCT06688578","Testing Effectiveness of a Stochastic Noise Stimulator to Immediately Improve Balance and Gait","Improvements in Balance and Gait Using a Stochastic Noise Stimulator: Short Term Response","Inclusion Criteria Older (ages 60+) and younger (aged 21-59) participants with no significant health history will be recruited from the community.\n\nExclusion Criteria\n\nAny person with a self-reported history of:\n\n* impaired proprioception\n* significant eye problems\n* neuromuscular disease\n* seizure\n* stroke\n* unmedicated diabetes\n* cardiovascular disease (except controlled hypertension)\n* renal disease or electrolyte imbalance\n* orthopedic disorders such as severe neck or back pain\n* uncontrolled high blood pressure (200\u002F110 or greater)\n* implanted electronic devices (pacemakers, defibrillators, implanted pumps or stimulator devices, cochlear, etc.)\n* psychotic medications or current psychotic symptoms\n* Any other psychiatric condition requiring hospitalization since 1991\n* recent history of alcohol or drug abuse within the past 6 months\n* inability to stand unassisted for 30 seconds or walk unassisted for 6 minutes",true,"ALL","21 Years",{"count":20,"type":21},120,"ESTIMATED","INTERVENTIONAL",[24],"NA","The goal of this intervention study is to determine if a new electronic stimulation device, similar to a TENS can improve balance and make walking easier in older individuals with reduced balance function. The main question aims to answer the following:\n\nCan using the device improve walking speed in older individuals?\n\nParticipants will be asked to perform a number of tasks while wearing the device:\n\nWalk for 6 minutes\n\n* Stand in place while having balance measured (eyes open and closed)\n* Stand on a foam block while having balance measured (eyes open and closed)\n* Sit in a chair that will tilt +\u002F- 20 degrees while wearing goggles that take videos of the participants eyes.",[27,28],"Vestibular Disorder","Aging",[30,31,32,33],"Balance and Gait","Stochastic Noise Stimulator","Neural degeneration","neuromodulation","RECRUITING","2026-06-19",{"date":37,"type":38},"2026-06-23","ACTUAL",{"date":40,"type":21},"2026-09-25",{"date":42,"type":21},"2027-05-31",{"name":44,"class":45},"Massachusetts Eye and Ear Infirmary","OTHER",2,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":4,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":17,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":4,"studyType":22,"phases":58,"briefSummary":59,"conditions":60,"keywords":61,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":76},"100639979","okt-with-gaze-and-postural-stabilization-on-vertigo-ms-and-qol-in-vbh-100639979","NCT07575074","OKT With Gaze and Postural Stabilization on Vertigo, MS and QOL in VBH","Effects of Optokinetic Training With Gaze and Postural Stabilization on Vertigo, Motion Sickness and Quality of Life in Vestibular Hypofunction","Inclusion Criteria:\n\n* • Male and female patients age 20 and 40 years\n\n  * Passengers who have motion sickness during travelling\n  * Patients of vestibular migraine who experience motion sickness\n  * Participants experiencing vertigo, dizziness or imbalance related to vestibular hypofunction over the past three months\n\nExclusion Criteria:\n\n* • Patients who have seasickness and simulator sickness excluded.\n\n  * Patients having vestibular disease and chronic neurological disease.\n  * Participants who have completed formal vestibular rehabilitation in last 6 months excluded\n  * Patients with severe visual impairments and orthopedic conditions excluded.","20 Years","40 Years",{"count":57,"type":21},32,[24],"The objective of this study will evaluate the effects of optokinetic training combined with postural stabilization and gaze stability exercises on motion sickness, balance, gaze stability, and quality of life in individuals with vestibular hypofunction.",[27],[62,63,64,65],"Balance","gaze stability","motion sickness","optokinetic training","NOT_YET_RECRUITING","2026-05-04",{"date":69,"type":38},"2026-05-08",{"date":71,"type":21},"2026-05-15",{"date":73,"type":21},"2026-09-14",{"name":75,"class":45},"Riphah International University",1,{"id":78,"slug":79,"hasResults":11,"nctId":80,"briefTitle":81,"officialTitle":81,"acronym":4,"eligibilityCriteria":82,"healthyVolunteers":11,"sex":17,"minAge":83,"maxAge":4,"enrollmentInfo":84,"targetDuration":4,"studyType":22,"phases":86,"briefSummary":87,"conditions":88,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":76},"100347149","vestibular-therapy-in-alzheimers-disease-100347149","NCT03799991","Vestibular Therapy in Alzheimer's Disease","Inclusion Criteria:\n\n* Diagnosis of AD based on the National Institute on Aging-Alzheimer Association 2011 criteria that is mild-moderate (CDR=0.5-2).\n* Age ≥ 60 years.\n* Vestibular loss defined as bilaterally impaired vestibular responses (semicircular canal or otolith responses).\n* Able to participate in study procedures including vestibular physiologic testing, balance and gait assessment, neurocognitive testing, and VT or active control.\n* Able to give informed consent, as further detailed in the Human Subjects section. The investigators anticipate that individuals who are too impaired to provide informed consent would also not be able to effectively participate in VT or active control.\n* Presence of a caregiver, defined as an individual who spends at least 10 hours per week with the patient. The caregiver must be able to participate in study procedures, specifically the text-messaging system. Both the VT and active control involve 8 weeks of once weekly visits and daily home exercises, and the investigators believe a caregiver would increase the likelihood of successful completion of either therapy.\n\nExclusion Criteria:\n\n* Diagnosis of severe AD (CDR≥3).\n* Diagnosis of mild cognitive impairment or diagnosis of non-AD dementia, for example Parkinson's disease dementia, Dementia with Lewy Bodies, vascular dementia, fronto-temporal dementia, and primary progressive aphasia.\n* Deemed unable to participate in study procedures and VT or active control, (e.g. patients with significant medical comorbidities, excessive agitation, or use of mobility aids such as a cane or walker.)\n* Use of daily vestibular suppressant medications, specifically anti-histamines and benzodiazepines, as this can alter the response to VT.\n* Lack of availability to participate in 8 weeks of VT or active control.","60 Years",{"count":85,"type":21},100,[24],"Nearly 2 out of 3 patients with Alzheimer's disease (AD) experience problems with balance and mobility, which places such patients at increased risk of falling. The vestibular (inner ear balance) system plays an important role in balance stability, and vestibular therapy (VT) is well-known to improve balance function in healthy older adults. In this study, the investigators will conduct a first-in-kind randomized clinical trial to evaluate whether vestibular therapy improves reduces falls in patients with AD, in whom this treatment has never been studied.",[89,27,90],"Vestibular Diseases","Alzheimer Disease","2026-01-09",{"date":93,"type":38},"2026-01-12",{"date":95,"type":38},"2022-08-22",{"date":97,"type":21},"2027-08-26",{"name":99,"class":45},"Johns Hopkins University",{"id":101,"slug":102,"hasResults":11,"nctId":103,"briefTitle":104,"officialTitle":104,"acronym":4,"eligibilityCriteria":105,"healthyVolunteers":16,"sex":17,"minAge":106,"maxAge":107,"enrollmentInfo":108,"targetDuration":4,"studyType":22,"phases":110,"briefSummary":111,"conditions":112,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":114,"lastUpdatePostDateStruct":115,"startDateStruct":117,"completionDateStruct":119,"leadSponsor":121,"locationsCount":76},"100471133","reading-outcomes-in-children-with-vestibular-loss-100471133","NCT05414903","Reading Outcomes in Children With Vestibular Loss","Inclusion Criteria:\n\n* Children will be required to have nonverbal problem-solving\u002Fintelligence scores within 1.5 SD of the mean (mean = 100, SD = 15, 1.5 SD of mean = 77 - 123).\n* Children with normal hearing must have thresholds ≤20 dB HL from 0.25 to 8 kHz.\n* Children with hearing loss must have pure-tone averages \\> 65 dB HL.\n\nExclusion Criteria:\n\n* Fail a vision screen at 20\u002F30\n* Have autism, blindness, or other optic disorders, cerebral palsy, significant neurologic involvement, uncorrectable vision problems, and intellectual disability.\n* Children with nonverbal problem-solving\u002Fintelligence scores \\> 123 or \\\u003C 77 will be excluded.\n* Each participant's current medications will be reviewed. Children taking medications known to result in oculomotor slowing will be excluded (i.e., anti-depressants, vestibular suppressants, sedatives, etc).","7 Years","18 Years",{"count":109,"type":21},90,[24],"Vestibular loss can co-occur with hearing loss causing dual sensory deficits. This project examines vestibular loss as a contributing factor to reading difficulties for children with hearing loss, where previously only the effects of hearing loss and subsequent language difficulties have been considered. These results are expected to influence the identification and habilitation of vestibular loss in children with hearing loss.",[27,113],"Hearing Loss, Sensorineural","2025-12-17",{"date":116,"type":38},"2025-12-23",{"date":118,"type":38},"2022-06-06",{"date":120,"type":21},"2026-06-30",{"name":122,"class":45},"Father Flanagan's Boys' Home",{"id":124,"slug":125,"hasResults":11,"nctId":126,"briefTitle":127,"officialTitle":128,"acronym":4,"eligibilityCriteria":129,"healthyVolunteers":11,"sex":17,"minAge":107,"maxAge":4,"enrollmentInfo":130,"targetDuration":4,"studyType":22,"phases":132,"briefSummary":133,"conditions":134,"keywords":4,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":137,"lastUpdatePostDateStruct":138,"startDateStruct":140,"completionDateStruct":142,"leadSponsor":144,"locationsCount":4},"100611269","evaluation-of-nystagmus-examination-using-wearable-ar-glasses-in-vertigo-patients-100611269","NCT07238387","Evaluation of Nystagmus Examination Using Wearable AR Glasses in Vertigo Patients","Evaluation of Nystagmus Examinations Conducted Using Wearable Augmented Reality Glasses in Vertigo Patients: A Randomized Equivalence Study","Inclusion Criteria:\n\n* Adults ≥18 years with vertigo\u002Fdizziness suggestive of a central or peripheral vestibular disorder.\n* Able to complete both AR-based and conventional oculomotor testing during the same visit (with \\~30-minute washout).\n* Provide written informed consent.\n* Adequate vision for eye-tracking and calibration (e.g., corrected visual acuity ≥20\u002F40 in each eye).\n* Willing and able to return for the follow-up visit.\n\nExclusion Criteria:\n\n* Use of vestibular-suppressant medications within 24 hours prior to testing (e.g., benzodiazepines, antihistamines, anticholinergics).\n* Ocular conditions that would interfere with reliable eye tracking (e.g., corrected visual acuity \\\u003C20\u002F40, dense cataract, severe ptosis\u002Fstrabismus, active ocular infection\u002Finflammation).\n* History of photosensitive epilepsy or seizure disorder triggered by visual stimuli.\n* Severe motion sickness\u002Fcybersickness or inability to tolerate the AR headset.\n* Significant cognitive impairment or psychiatric condition precluding informed consent or protocol compliance.\n* Pregnant or breastfeeding (per investigator judgment and IRB policy).\n* Any other condition that, in the investigator's opinion, would make participation unsafe or confound study results.",{"count":131,"type":21},200,[24],"Background and Purpose:\n\nVertigo is common in emergency and outpatient settings, yet standard oculomotor testing usually requires dedicated equipment and exam rooms. This study evaluates whether nystagmus examinations performed with wearable augmented-reality (AR) glasses are equivalent to conventional examination-room testing for classifying central vs. peripheral vertigo. The investigators also assess diagnostic accuracy, patient tolerability, and the reliability of AR-based interpretation (test-retest and inter-rater).\n\nStudy Design:\n\nProspective, single-center, within-subject randomized equivalence study at Kaohsiung Chang Gung Memorial Hospital. Each participant completes both AR-based and conventional oculomotor testing in a randomized order during the same visit, separated by a 30-minute washout. The study uses an evaluator-blind approach: de-identified trajectories are reviewed offline by independent experts who are masked to test modality. A follow-up visit (\\~1 week) captures adverse events and patient experience.\n\nParticipants:\n\nAdults (≥18 years) presenting with vertigo who can tolerate the AR headset and provide consent. Key exclusions include conditions that prevent reliable eye-tracking (e.g., corrected visual acuity \\\u003C20\u002F40), recent use of vestibular suppressants (within 24 hours), and other factors limiting cooperation or safety.\n\nInterventions and Procedures:\n\nThe AR system records eye movements and presents standardized visual stimuli. Conventional testing follows current clinical standards (e.g., Frenzel\u002Foculomotor exam). All recordings are stored securely for blinded review.\n\nOutcomes:\n\nPrimary endpoint: Equivalence of diagnostic agreement (central vs. peripheral) between AR-based and conventional methods, quantified by Cohen's kappa (κ) with a predefined equivalence margin.\n\nSecondary endpoints: (1) Diagnostic accuracy of the AR method in a clinically-indicated imaging subgroup (MRI preferred; CT as needed) using a sequential evaluation strategy; (2) Patient discomfort\u002Ftolerability using VAS and CSQ-VR, compared between modalities; (3) Test-retest reliability of AR-based classifications; (4) Inter-rater reliability between independent evaluators, with a third reader adjudicating discordant cases; (5) prespecified subgroup analyses by age, medical history, and vestibular function.\n\nSample Size and Duration:\n\nApproximately 200 participants will be enrolled (target \\~180 evaluable after \\~10% attrition). Total study duration is \\~2 years, including enrollment, follow-up, and analysis.\n\nRisks and Benefits:\n\nBoth tests are non-invasive. Potential transient discomfort (e.g., eye strain or cybersickness) will be monitored. There may be no direct benefit to participants; however, results could support broader, more accessible, and standardized vertigo assessment.\n\nData Security and Privacy:\n\nAll data are de-identified, stored on secure platforms with role-based access and audit trails. Safety events are monitored and graded, and protocol deviations are handled per Good Clinical Practice.",[135,27,136],"Vertigo","Nystagmus","2025-11-18",{"date":139,"type":38},"2025-11-20",{"date":141,"type":21},"2026-01-01",{"date":143,"type":21},"2029-12-31",{"name":145,"class":45},"Chang Gung Memorial Hospital",{"id":147,"slug":148,"hasResults":11,"nctId":149,"briefTitle":150,"officialTitle":151,"acronym":152,"eligibilityCriteria":153,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":154,"enrollmentInfo":155,"targetDuration":4,"studyType":22,"phases":157,"briefSummary":158,"conditions":159,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":163,"lastUpdatePostDateStruct":164,"startDateStruct":166,"completionDateStruct":168,"leadSponsor":170,"locationsCount":46},"100487074","stableeyes-with-active-neurofeedback-100487074","NCT05622344","StableEyes With Active Neurofeedback","StableEyes With Active Neurophysiological Feedback","SWAN","Inclusion Criteria:\n\n1. Provision of signed and dated informed consent form\n2. Stated willingness to comply with all study procedures and availability for the duration of the study\n3. In good general health as evidenced by medical history or diagnosed with unilateral vestibular schwannoma\n4. Willing to adhere to the SWAN and\u002For vestibular rehabilitation regimen\n\nExclusion Criteria:\n\n1. Current use of anti-nausea medication\n2. Presence of cervical spine pathology that limits head motion to \\\u003C 30 degrees in the horizontal or vertical plane (i.e. degenerative disc disease, rheumatoid arthritis)\n3. Any orthopedic pathology that prevents walking or standing independently (i.e. recent surgery)\n4. Legal blindness (20\u002F200 or worse visual acuity)\n5. Treatment using a motion sickness investigational drug or other motion sickness behavioral intervention within 30 days","70 Years",{"count":156,"type":21},48,[24],"The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.",[27,160,161,162],"Vestibular Schwannoma","Space Motion Sickness","Motion Sickness","2025-11-06",{"date":165,"type":38},"2025-11-10",{"date":167,"type":38},"2022-08-08",{"date":169,"type":21},"2026-09-30",{"name":99,"class":45},{"id":172,"slug":173,"hasResults":11,"nctId":174,"briefTitle":175,"officialTitle":176,"acronym":177,"eligibilityCriteria":178,"healthyVolunteers":11,"sex":17,"minAge":179,"maxAge":180,"enrollmentInfo":181,"targetDuration":4,"studyType":183,"phases":4,"briefSummary":184,"conditions":185,"keywords":189,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":199,"lastUpdatePostDateStruct":200,"startDateStruct":202,"completionDateStruct":204,"leadSponsor":206,"locationsCount":76},"100533737","vestibular-and-postural-function-in-children-suspected-of-balance-disorders-100533737","NCT06229704","Vestibular and Postural Function in Children Suspected of Balance Disorders","Vestibular ASsessment In Children - Balance Function in Normal Children and Specific Risk Groups (VASIC)","VASIC","Inclusion Criteria:\n\n* Children in the age of 6 months to 10 years\n* Delayed gross motor development and\u002For dizziness\u002Fbalance problems.\n* Written informed consent from the parents.\n\nExclusion Criteria:\n\n* Visual impairment to such a degree that the child is not able to maintain fixation on a dot one meter away.\n* Congenital nystagmus\n* Compromised eye muscle mobility\n* VEMP-electrode allergy\n* History of symptomatic head or neck trauma\n* Prescription of medicine which alters vestibular outputs (for instance sedative antihistamines)","6 Months","10 Years",{"count":182,"type":21},30,"OBSERVATIONAL","The goal of this prospective cohort study is to investigate the vestibular function in children suspected of balance disorders, and to follow up on their balance progressions after rehabilitation. The main hypothesis of the study is that delayed gross motor development and symptoms of dizziness and balance problems in some children are caused by vestibular dysfunction. The investigators expect that early detection and rehabilitation by a physiotherapist will improve the balance ability for the child. The participants will be children in the age of 6 months to 10 years with delayed gross motor development and\u002For with dizziness\u002Fbalance problems. The test protocol consists of questionnaires, hearing screening and vestibular and postural assessments.",[186,27,187,188],"Children, Only","Vestibular Function Disorder","Development Delay",[190,191,192,193,194,195,196,197,198],"Vestibular dysfunction","Balance problem","Children","Dizziness","Vestibular assessment","video Head Impulse Test","Vestibular Evoked Myogenic Potential","Computerized Dynamic Posturography","Delayed gross motor development","2025-08-21",{"date":201,"type":38},"2025-08-26",{"date":203,"type":38},"2025-08-20",{"date":205,"type":21},"2028-12",{"name":207,"class":45},"Gødstrup Hospital",{"id":209,"slug":210,"hasResults":11,"nctId":211,"briefTitle":212,"officialTitle":176,"acronym":177,"eligibilityCriteria":213,"healthyVolunteers":11,"sex":17,"minAge":214,"maxAge":180,"enrollmentInfo":215,"targetDuration":4,"studyType":183,"phases":4,"briefSummary":216,"conditions":217,"keywords":220,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":199,"lastUpdatePostDateStruct":223,"startDateStruct":224,"completionDateStruct":225,"leadSponsor":226,"locationsCount":76},"100533738","vestibular-and-postural-function-in-an-unselected-group-of-children-with-sensorineural-hearing-loss-100533738","NCT06229717","Vestibular and Postural Function in an Unselected Group of Children With Sensorineural Hearing Loss","Inclusion Criteria:\n\n* Children in the age of 3-10 years\n* Uni- or bilateral sensorineural hearing loss \\> 20 dB bone conduction pure tone average measured at frequencies 0.5, 1, 2, 4 kHz\n* Written informed consent from the parents.\n\nExclusion Criteria:\n\n* Previous inner ear surgery\n* Visual impairment to such a degree that the child is not able to maintain fixation on a dot one meter away.\n* Congenital nystagmus\n* Compromised eye muscle mobility\n* VEMP-electrode allergy\n* History of symptomatic head or neck trauma\n* Prescription of medicine which alters vestibular outputs (for instance sedative antihistamines)","3 Years",{"count":156,"type":21},"The goal of this prospective cohort study is to investigate the vestibular function in children with unilateral or bilateral sensorineural hearing loss. The main hypothesis of the study is that abnormal vestibular test results will be found in 20-30 % of the children with sensorineural hearing loss. The participants will be children in the age of 3-10 years with sensorineural hearing loss. The test protocol consists of questionnaires and vestibular and postural assessments.",[186,27,218,219],"Vestibular Function","Sensorineural Hearing Loss",[190,191,192,221,193,194,195,196,197,222],"Hearing Loss","Quality of life",{"date":201,"type":38},{"date":203,"type":38},{"date":205,"type":21},{"name":207,"class":45},{"id":228,"slug":229,"hasResults":11,"nctId":230,"briefTitle":231,"officialTitle":232,"acronym":233,"eligibilityCriteria":234,"healthyVolunteers":11,"sex":17,"minAge":214,"maxAge":235,"enrollmentInfo":236,"targetDuration":4,"studyType":22,"phases":238,"briefSummary":239,"conditions":240,"keywords":241,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":247,"lastUpdatePostDateStruct":248,"startDateStruct":250,"completionDateStruct":252,"leadSponsor":254,"locationsCount":76},"100529696","vestibular-infant-screening---rehabilitation-100529696","NCT06177132","Vestibular Infant Screening - Rehabilitation","Vestibular Infant Screening - Rehabilitation (VIS-REHAB): Protocol for a Randomised Controlled Trial on Vestibular Rehabilitation Therapy (VRT) in Vestibular-impaired Children","VIS-REHAB","Inclusion Criteria:\n\n* Patients with identified vestibular dysfunction\n* With or without concomitant hearing loss and\u002For cochlear implant (CI)\n\nExclusion Criteria:\n\n* Children incapable to understand simple instructions (due to severe cognitive disorders, impaired language comprehension, etc.)\n* Severe disorders of other primary sensory input systems for balance function\n* Severe neuromotor disorders (incapable of independent standing and walking)\n* Severe muscle tone disorders (e.g. cerebral palsy)\n* Severe orthopaedic dysfunctions\n* Patients with vision problems that cannot be corrected for\n* Children with planned CI-surgery within 5 months before or during the study period","17 Years",{"count":237,"type":21},60,[24],"The goal of this clinical trial is to investigate the short-term effect of a structured, combined postural control and gaze stabilisation protocol (VIS-REHAB protocol) in a group of vestibular-impaired children of different age categories (3-17 years). The main questions it aims to answer are:\n\n* What is the short-term effect of the VIS-REHAB protocol?\n* What are the most important factors that may influence the effect of and outcome after application of the VIS-REHAB protocol?\n\nThe participant will undergo both an active rehabilitation program (VIS-REHAB protocol) and a period during which physical therapy is discontinued (CTRL protocol).:\n\n\\- VIS-REHAB protocol: Postural control (static and dynamic postural stability exercises), gaze stability exercises (oculomotor function and VOR-exercises) \\& general gross motor training with focus on gaze stability and postural control.\n\nResearchers will compare the VIS-REHAB protocol with receiving no therapy (CTRL protocol) to evaluate potential enhancements in postural stability, gaze stability, motor performance and quality of life.",[27],[242,243,244,245,246],"Therapy","Vestibular Rehabilitation Therapy","VRT","Gaze stability","Postural control","2024-09-05",{"date":249,"type":38},"2024-09-19",{"date":251,"type":21},"2025-11",{"date":253,"type":21},"2027-10",{"name":255,"class":45},"University Hospital, Ghent",{"id":257,"slug":258,"hasResults":11,"nctId":259,"briefTitle":260,"officialTitle":260,"acronym":4,"eligibilityCriteria":261,"healthyVolunteers":16,"sex":17,"minAge":262,"maxAge":263,"enrollmentInfo":264,"targetDuration":4,"studyType":183,"phases":4,"briefSummary":266,"conditions":267,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":269,"lastUpdatePostDateStruct":270,"startDateStruct":272,"completionDateStruct":274,"leadSponsor":276,"locationsCount":76},"100415139","balanced-growth-the-involvement-of-the-vestibular-system-in-a-childs-cognitive-and-motor-development-100415139","NCT04685746","BALANCED GROWTH: The Involvement of the Vestibular System in a Child's Cognitive and Motor Development","For typically developing children\n\nExclusion Criteria:\n\n* Having a (permanent) hearing loss\n* Having a (permanent) vestibular loss\n* Having a motor dysfunction\n* IQ \\\u003C 70\n\nFor vestibular-impaired children\n\nInclusion Criteria:\n\n* Recently (\\\u003C 6 months) tested at the Ghent University Hospital\n* Diagnosed with a vestibular impairment (= alteration on at least one of the vestibular function tests: caloric, rotatory chair, vHIT, cVEMP and\u002For oVEMP test)\n\nFor neurodevelopmental group\n\nInclusion Criteria:\n\n• Diagnosed by a (neuro)psychiatric team with Autism Spectrum Disorder, Attention deficit\u002FHyperactivitiy Disorder and\u002For Developmental Coordination Disorder","6 Years","13 Years",{"count":265,"type":21},250,"When a vestibular dysfunction occurs at birth or in early stages of life, one might expect that this may have an enormous impact on a child's development. It is known that a severe congenital or early acquired vestibular deficit in children results in delayed psychomotor milestones. Later in life, children with a vestibular dysfunction may have difficulties with several balance tasks and additional cognitive, motor and\u002For psychosocial performances. While a few authors have suggested that there is indeed an influence of a vestibular dysfunction upon these different developmental domains (cognitive, motor, educational and psychosocial development), which can be supported by findings in clinical practice as well, literature concerning this topic remains fairly limited. On the other hand, several studies have shown that children with known difficulties in motor and\u002For cognitive functions have more difficulties in vestibular performances in comparison with their unaffected peers. Although more frequently discussed, the literature on this population is rather scarce too.\n\nTherefore, the current project aims to investigate the relationship with and the involvement of the vestibular system in the motor and cognitive development of school-aged children.",[27,268],"Neurodevelopmental Disorders","2023-11-27",{"date":271,"type":38},"2023-11-30",{"date":273,"type":38},"2019-07-29",{"date":275,"type":21},"2028-10-31",{"name":277,"class":45},"University Ghent",{"id":279,"slug":280,"hasResults":11,"nctId":281,"briefTitle":282,"officialTitle":283,"acronym":4,"eligibilityCriteria":284,"healthyVolunteers":11,"sex":17,"minAge":107,"maxAge":83,"enrollmentInfo":285,"targetDuration":4,"studyType":22,"phases":287,"briefSummary":288,"conditions":289,"keywords":4,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":291,"lastUpdatePostDateStruct":292,"startDateStruct":294,"completionDateStruct":296,"leadSponsor":298,"locationsCount":4},"100503158","new-rehabilitation-protocol-for-patients-with-pppd-100503158","NCT05831618","New Rehabilitation Protocol for Patients With PPPD","New Rehabilitation Protocol for Patients With Persistent Postural Perceptual Dizziness","Inclusion Criteria:\n\n* Diagnostic criteria established for PPPD by the Barany Society (Staab et al., 2017) will be adopted\n\nExclusion Criteria:\n\n* Patients with neurological, otological or psychiatric disorders other than PPPD will be excluded.",{"count":286,"type":21},40,[24],"The investigators will test a new rehabilitation protocol on patients with persistent postural perceptual dizziness (PPPD). The investigators hypothesize that patients with PPPD, in the absence of vestibular deficits, do not benefit from standard vestibular rehabilitation but instead need a rehabilitation that acts on visual and postural stability, through training of saccadic movements in dynamic contexts of cognitive-motor dual-task and rehabilitation of postural stability.",[290,62,27,193],"Rehabilitation","2023-07-12",{"date":293,"type":38},"2023-07-13",{"date":295,"type":21},"2023-07-30",{"date":297,"type":21},"2026-12-31",{"name":299,"class":45},"I.R.C.C.S. Fondazione Santa Lucia",{"id":301,"slug":302,"hasResults":11,"nctId":303,"briefTitle":304,"officialTitle":304,"acronym":4,"eligibilityCriteria":305,"healthyVolunteers":16,"sex":17,"minAge":107,"maxAge":4,"enrollmentInfo":306,"targetDuration":4,"studyType":22,"phases":307,"briefSummary":308,"conditions":309,"keywords":4,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":314,"lastUpdatePostDateStruct":315,"startDateStruct":317,"completionDateStruct":319,"leadSponsor":321,"locationsCount":4},"100464041","meniers-disease---bone-density-study-100464041","NCT05322538","Menier's Disease - Bone Density Study","Inclusion Criteria:\n\n* Definite Meniere's disease\n\nExclusion Criteria:\n\n* hyperthyroidism\n* hyperparathyroidism\n* acromegaly\n* hypogonadism\n* diabetes melitus\n* chronic renal failure\n* alcoholism\n* cushing syndrome\n* rheumatoid arthritis\n* systemic lupus erythematosus\n* ankylosing spondylitis\n* inflammatory bowel disease\n* obstructive lung disease\n* sarcoidosis\n* amyloidosis\n* celiac disease.\n* chronic treatment with bisphosphonates\n* chronic treatment with glucocorticoids\n* chronic treatment with androgen deprivation therapy\n* chronic treatment with gonadotropin releasing hormone agonist chronic treatment with aromatase inhibitor chronic treatment with loop diuretics chronic treatment with proton pump inhibitors chronic treatment with anti-seizure drugs chronic treatment with warfarin chronic treatment with SSRI chronic treatment with alpha or beta-blockers",{"count":237,"type":21},[24],"Meniere's disease is a progressive and debilitating inner ear disease characterised by vertigo and hearing loss. Several studies have linked Menierws disease with lower bone density and lower vitamin D levels. In the current prospective study definite Meniere's patients will be followed over a period of 2 year, during which repetitive measurements of bone density, vitamin D plasma levels, blood pressure as well as hearing and vestibular tests will be made. Results will be compared to healthy controls.",[310,311,312,313,27],"Meniere Disease","Osteoporosis","Osteopenia","Vitamin D Deficiency","2022-08-02",{"date":316,"type":38},"2022-08-03",{"date":318,"type":21},"2022-10-01",{"date":320,"type":21},"2028-12-31",{"name":322,"class":45},"HaEmek Medical Center, Israel"]